Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells

Molecular Carcinogenesis

Volumn 55, Issue 8, 2016, Pages 1275-1289

  Dai, Qinsheng ^a   Yin, Qian ^a   Wei, Libin ^a   Zhou, Yuxin ^a   Qiao, Chen ^a   Guo, Yongjian ^b   Wang, Xiaotang ^b   Ma, Shiping ^a   Lu, Na ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

aerobic glycolysis; HIF 1 ; oroxylin A; oxidative phosphorylation; ROS

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; HEXOKINASE; HEXOKINASE II; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE A; LACTIC ACID; MATRIX METALLOPROTEINASE; MESSENGER RNA; OROXYLIN A; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROCASPASE 3; PROTEIN P21; PROTEIN P27; REACTIVE OXYGEN METABOLITE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HEPG2 CELL LINE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY CHAIN;

EID: 84977506101     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22369     Document Type: Article

References (45)

1. Maddocks OD, Vousden KH. Metabolic regulation by p53. J Mol Med (Berl) 2011; 89:237–245.
2. Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer 2011; 11:85–95.
3. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144:646–674.
4. Shaw RJ. Glucose metabolism and cancer. Curr Opin Cell Biol 2006; 18:598–608.
5. Warburg O. On the origin of cancer cells. Science 1956; 123:309–314.
6. Yeung SJ, Pan J, Lee MH. Roles of p53, MYC and HIF-1 in regulating glycolysis—the seventh hallmark of cancer. Cell Mol Life Sci 2008; 65:3981–3999.
7. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 2009; 324:1029–1033.
8. Newsholme EA, Crabtree B, Ardawi MS. The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Biosci Rep 1985; 5:393–400.
9. Tatum JL, Kelloff GJ, Gillies RJ. Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 2006; 82:699–757.
10. Salminen A, Kaarniranta K. Glycolysis links p53 function with NF-kappaB signaling: Impact on cancer and aging process. J Cell Physiol 2010; 224:1–6.
11. Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: Metabolism and growth control in tumour suppression. Nat Rev Cancer 2009; 9:563–575.
12. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3:187–197.
13. Heldin CH, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure—An obstacle in cancer therapy. Nat Rev Cancer 2004; 4:806–813.
14. Acker T, Plate KH. A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology. J Mol Med (Berl) 2002; 80:562–575.
15. Kudo T, Ueda M, Kuge Y. Imaging of HIF-1-active tumor hypoxia using a protein effectively delivered to and specifically stabilized in HIF-1-active tumor cells. J Nucl Med 2009; 50:942–949.
16. Manalo DJ, Rowan A, Lavoie T. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005; 105:659–669.
17. Kuzmanov A, Wielockx B, Rezaei M, Kettelhake A, Breier G. Overexpression of factor inhibiting HIF-1 enhances vessel maturation and tumor growth via platelet-derived growth factor-C. Int J Cancer 2012; 131:E603–E613.
18. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3:177–185.
19. Kim JW, Gao P, Liu YC, Semenza GL, Dang CV. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol 2007; 27:7381–7393.
20. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med 2003; 9:677–684.
21. Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006; 25:4633–4646.
22. Li HN, Nie FF, Liu W, et al. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. Toxicology 2009; 257:80–85.
23. Dai Q, Yin Y, Liu W, et al. Two p53-related metabolic regulators, TIGAR and SCO2, contribute to oroxylin A-mediated glucose metabolism in human hepatoma HepG2 cells. Int J Biochem Cell Biol 2013; 45:1468–1478.
24. Kurtoglu M, Gao N, Shang J, et al. Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation. Mol Cancer Ther 2007; 6:3049–3058.
25. Li HB, Chen F. Isolation and purification of baicalein, wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography. J Chromatogr 2005; 1074:107–110.
26. Chen Y, Lu N, Ling Y, et al. Wogonoside inhibits lipopolysaccharide-induced angiogenesis in vitro and in vivo via toll-like receptor 4 signal transduction. Toxicology 2009; 259:10–17.
27. Koh MY, Spivak-Kroizman TR, Powis G. Inhibiting the hypoxia response for cancer therapy: The new kid on the block. Clin Cancer Res 2009; 15:5945–5946.
28. Ke Q, Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 2006; 70:1469–1480.
29. Iqbal MA, Gupta V, Gopinath P, Mazurek S, Bamezai RN. Pyruvate kinase M2 and cancer: An updated assessment. FEBS Lett 2014; 588:2685–2692.
30. Anavi S, Hahn-Obercyger M, Madar Z, Tirosh O. Mechanism for HIF-1 activation by cholesterol under normoxia: A redox signaling pathway for liver damage. Free Radic Biol Med 2014; 71:61–69.
31. Kirito K, Hu Y, Komatsu N. HIF-1 prevents the overproduction of mitochondrial ROS after cytokine stimulation through induction of PDK-1. Cell Cycle 2009; 8:2844–2849.
32. Mitchell P, Moyle J. Chemiosmotic hypothesis of oxidative phosphorylation. Nature 1967; 213:137–139.
33. Bayley JP, Devilee P. The Warburg effect in 2012. Curr Opin Oncol 2012; 24:62–67.
34. Upadhyay M, Samal J, Kandpal M, Singh OV, Vivekanandan P. The Warburg effect: Insights from the past decade. Pharmacol Ther 2013; 137:318–330.
35. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11:325–337.
36. Le A, Cooper CR, Gouw AM, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 2010; 107:2037–2042.
37. Lin S, Hoffmann K, Schemmer P. Treatment of hepatocellular carcinoma: A systematic review. Liver Cancer 2012; 1:144–158.
38. Luo D, Wang Z, Wu J, Jiang C. The role of hypoxia inducible factor-1 in hepatocellular carcinoma. Biomed Res Int 2014; 2014:409272.
39. Unruh A, Ressel A, Mohamed HG. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene 2003; 22:3213–3220.
40. Semenza GL. Hypoxia clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 2000; 35:71–103.
41. Tamada M, Suematsu M, Saya H. Pyruvate kinase M2: Multiple faces for conferring benefits on cancer cells. Clin Cancer Res 2012; 18:5554–5561.
42. Weinberg F, Chandel NS. Mitochondrial metabolism and cancer. Ann N Y Acad Sci 2009; 1177:66–73.
43. Semenza GL. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 2009; 19:12–16.
44. Shi DY, Xie FZ, Zhai C, Stern JS, Liu Y, Liu SL. The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells. Mol Cancer 2009; 8:32.
45. Wu M, Neilson A, Swift AL, et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 2007; 292:C125–C136.